Shares Outstanding: 98.40M
The shares outstanding is 98.40M. It is below its 12-month average by 0.32% (98.71M).
STE Shares Outstanding
Reported quarterly weighted average share count; no daily interpolation.
STE Average Shares Outstanding Chart
STE Current vs Average Shares Outstanding Chart
STE Shares Outstanding Metrics
SHARES OUTSTANDING
98.40M
SHARES OUTSTANDING AVG TTM
98.71M
SHARES OUTSTANDING AVG 3Y
99.04M
SHARES OUTSTANDING AVG 5Y
99.51M
SHARES OUTSTANDING AVG 10Y
92.25M
SHARES OUTSTANDING AVG 15Y
81.82M
SHARES OUTSTANDING AVG 20Y
76.93M
CURRENT VS TTM AVG
-0.32%
CURRENT VS 3Y AVG
-0.64%
CURRENT VS 5Y AVG
-1.11%
CURRENT VS 10Y AVG
+6.66%
CURRENT VS 15Y AVG
+20.27%
CURRENT VS 20Y AVG
+27.90%
Share Structure
Shares Outstanding
98.20M
Float Shares
N/A
Stock Price
$210.60
Market Cap
$20.5B
Quarterly Shares Outstanding History
| Period | Weighted Average Shares | QoQ Change |
|---|---|---|
| Q4 2026 | 98.40M | -0.40% |
| Q3 2025 | 98.80M | +0.00% |
| Q2 2025 | 98.80M | +0.00% |
| Q1 2025 | 98.80M | +0.04% |
| Q4 2025 | 98.76M | -0.19% |
| Q3 2024 | 98.94M | -0.26% |
| Q2 2024 | 99.20M | -0.17% |
| Q1 2024 | 99.38M | +0.53% |
| Q4 2024 | 98.85M | -0.51% |
| Q3 2023 | 99.35M | -0.05% |
| Q2 2023 | 99.41M | +0.17% |
| Q1 2023 | 99.24M | -0.33% |
| Q4 2023 | 99.57M | -0.60% |
| Q3 2022 | 100.17M | +0.20% |
| Q2 2022 | 99.97M | -0.75% |
| Q1 2022 | 100.72M | -0.07% |
| Q4 2022 | 100.80M | -0.03% |
| Q3 2021 | 100.83M | +0.14% |
| Q2 2021 | 100.69M | +10.66% |
| Q1 2021 | 90.99M | +5.76% |
| Q4 2021 | 86.04M | +0.01% |
| Q3 2020 | 86.03M | +0.22% |
| Q2 2020 | 85.84M | +0.20% |
| Q1 2020 | 85.68M | +0.00% |
| Q4 2020 | 85.68M | +0.06% |
| Q3 2019 | 85.63M | -0.08% |
| Q2 2019 | 85.69M | +0.15% |
| Q1 2019 | 85.57M | +0.14% |
| Q4 2019 | 85.45M | +0.01% |
| Q3 2018 | 85.44M | -0.04% |
| Q2 2018 | 85.48M | -0.04% |
| Q1 2018 | 85.51M | -0.04% |
| Q4 2018 | 85.54M | -0.20% |
| Q3 2017 | 85.72M | -0.17% |
| Q2 2017 | 85.87M | +0.17% |
| Q1 2017 | 85.72M | +0.22% |
| Q4 2017 | 85.53M | +0.53% |
| Q3 2016 | 85.07M | -1.46% |
| Q2 2016 | 86.33M | -0.21% |
| Q1 2016 | 86.52M | +0.18% |
| Q4 2016 | 86.37M | +11.14% |
| Q3 2015 | 77.71M | +28.73% |
| Q2 2015 | 60.37M | +0.14% |
| Q1 2015 | 60.29M | +0.14% |
| Q4 2015 | 60.20M | +0.09% |
| Q3 2014 | 60.15M | +0.21% |
| Q2 2014 | 60.02M | +0.34% |
| Q1 2014 | 59.81M | +0.12% |
| Q4 2014 | 59.74M | +0.10% |
| Q3 2013 | 59.69M | -0.13% |
| Q2 2013 | 59.76M | -0.05% |
| Q1 2013 | 59.79M | +0.82% |
| Q4 2013 | 59.30M | +0.56% |
| Q3 2012 | 58.97M | +0.31% |
| Q2 2012 | 58.79M | +0.82% |
| Q1 2012 | 58.31M | +0.92% |
| Q4 2012 | 57.78M | -0.78% |
| Q3 2011 | 58.24M | -1.92% |
| Q2 2011 | 59.38M | -1.20% |
| Q1 2011 | 60.10M | -0.01% |
| Q4 2011 | 60.11M | -0.11% |
| Q3 2010 | 60.18M | +0.21% |
| Q2 2010 | 60.05M | +1.10% |
| Q1 2010 | 59.40M | +0.74% |
| Q4 2010 | 58.96M | -1.33% |
| Q3 2009 | 59.76M | +0.87% |
| Q2 2009 | 59.24M | +0.44% |
| Q1 2009 | 58.98M | +0.55% |
| Q4 2009 | 58.66M | -0.98% |
| Q3 2008 | 59.24M | -1.88% |
| Q2 2008 | 60.38M | +1.22% |
| Q1 2008 | 59.65M | -4.13% |
| Q4 2008 | 62.22M | -2.86% |
| Q3 2007 | 64.05M | -0.25% |
| Q2 2007 | 64.21M | -2.74% |
| Q1 2007 | 66.02M | +2.28% |
| Q4 2007 | 64.54M | +0.00% |
| Q3 2006 | 64.54M | -1.37% |
| Q2 2006 | 65.44M | -1.96% |
| Q1 2006 | 66.75M | -2.58% |
| Q4 2006 | 68.51M | +0.00% |
| Q3 2005 | 68.51M | +0.17% |
| Q2 2005 | 68.40M | -1.34% |
| Q1 2005 | 69.33M | -0.79% |
| Q4 2005 | 69.88M | +0.00% |
| Q3 2004 | 69.88M | -0.14% |
| Q2 2004 | 69.97M | -0.70% |
| Q1 2004 | 70.47M | +1.44% |
| Q4 2004 | 69.47M | -2.56% |
| Q3 2003 | 71.30M | +1.51% |
| Q2 2003 | 70.24M | -1.93% |
| Q1 2003 | 71.62M | +3.36% |
| Q4 2003 | 69.29M | -3.23% |
| Q3 2002 | 71.60M | +1.11% |
| Q2 2002 | 70.81M | -0.68% |
| Q1 2002 | 71.30M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Shares Outstanding Formula & Definition
Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shares Outstanding FAQ
- What is the shares outstanding for STERIS plc (STE)?
- The shares outstanding for STE stock is 98.40M.
- What is the TTM average shares outstanding for STERIS plc (STE)?
- The TTM average shares outstanding for STE stock is 98.71M.
- What is the 3Y average shares outstanding for STERIS plc (STE)?
- The 3Y average shares outstanding for STE stock is 99.04M.
- What is the 5Y average shares outstanding for STERIS plc (STE)?
- The 5Y average shares outstanding for STE stock is 99.51M.
- What is the 10Y average shares outstanding for STERIS plc (STE)?
- The 10Y average shares outstanding for STE stock is 92.25M.
- What is the 15Y average shares outstanding for STERIS plc (STE)?
- The 15Y average shares outstanding for STE stock is 81.82M.
- What is the 20Y average shares outstanding for STERIS plc (STE)?
- The 20Y average shares outstanding for STE stock is 76.93M.
STE Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2026-03-31 | 98.40M |
| 2025-12-31 | 98.80M |
| 2025-09-30 | 98.80M |
| 2025-06-30 | 98.80M |
| 2025-03-31 | 98.76M |
| 2024-12-31 | 98.94M |
| 2024-09-30 | 99.20M |
| 2024-06-30 | 99.38M |
| 2024-03-31 | 98.85M |
| 2023-12-31 | 99.35M |
| 2023-09-30 | 99.41M |
| 2023-06-30 | 99.24M |
| 2023-03-31 | 99.57M |
| 2022-12-31 | 100.17M |
| 2022-09-30 | 99.97M |
| 2022-06-30 | 100.72M |
| 2022-03-31 | 100.80M |
| 2021-12-31 | 100.83M |
| 2021-09-30 | 100.69M |
| 2021-06-30 | 90.99M |
| 2021-03-31 | 86.04M |
| 2020-12-31 | 86.03M |
| 2020-09-30 | 85.84M |
| 2020-06-30 | 85.68M |
| 2020-03-31 | 85.68M |
| 2019-12-31 | 85.63M |
| 2019-09-30 | 85.69M |
| 2019-06-30 | 85.57M |
| 2019-03-31 | 85.45M |
| 2018-12-31 | 85.44M |
| 2018-09-30 | 85.48M |
| 2018-06-30 | 85.51M |
| 2018-03-31 | 85.54M |
| 2017-12-31 | 85.72M |
| 2017-09-30 | 85.87M |
| 2017-06-30 | 85.72M |
| 2017-03-31 | 85.53M |
| 2016-12-31 | 85.07M |
| 2016-09-30 | 86.33M |
| 2016-06-30 | 86.52M |
| 2016-03-31 | 86.37M |
| 2015-12-31 | 77.71M |
| 2015-09-30 | 60.37M |
| 2015-06-30 | 60.29M |
| 2015-03-31 | 60.20M |
| 2014-12-31 | 60.15M |
| 2014-09-30 | 60.02M |
| 2014-06-30 | 59.81M |
| 2014-03-31 | 59.74M |
| 2013-12-31 | 59.69M |
| 2013-09-30 | 59.76M |
| 2013-06-30 | 59.79M |
| 2013-03-31 | 59.30M |
| 2012-12-31 | 58.97M |
| 2012-09-30 | 58.79M |
| 2012-06-30 | 58.31M |
| 2012-03-31 | 57.78M |
| 2011-12-31 | 58.24M |
| 2011-09-30 | 59.38M |
| 2011-06-30 | 60.10M |
| 2011-03-31 | 60.11M |
| 2010-12-31 | 60.18M |
| 2010-09-30 | 60.05M |
| 2010-06-30 | 59.40M |
| 2010-03-31 | 58.96M |
| 2009-12-31 | 59.76M |
| 2009-09-30 | 59.24M |
| 2009-06-30 | 58.98M |
| 2009-03-31 | 58.66M |
| 2008-12-31 | 59.24M |
| 2008-09-30 | 60.38M |
| 2008-06-30 | 59.65M |
| 2008-03-31 | 62.22M |
| 2007-12-31 | 64.05M |
| 2007-09-30 | 64.21M |
| 2007-06-30 | 66.02M |
| 2007-03-31 | 64.54M |
| 2006-12-31 | 64.54M |
| 2006-09-30 | 65.44M |
| 2006-06-30 | 66.75M |
| 2006-03-31 | 68.51M |
| 2005-12-31 | 68.51M |
| 2005-09-30 | 68.40M |
| 2005-06-30 | 69.33M |
| 2005-03-31 | 69.88M |
| 2004-12-31 | 69.88M |
| 2004-09-30 | 69.97M |
| 2004-06-30 | 70.47M |
| 2004-03-31 | 69.47M |
| 2003-12-31 | 71.30M |
| 2003-09-30 | 70.24M |
| 2003-06-30 | 71.62M |
| 2003-03-31 | 69.29M |
| 2002-12-31 | 71.60M |
| 2002-09-30 | 70.81M |
| 2002-06-30 | 71.30M |
Related Metrics
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Daniel A. Carestio